Sun Pharma Surges On Agreement To Sell Generic Drugs In China

Shares of Dilip Shanghvi-led Sun Pharma rose as much as 4.69 per cent to hit an intraday high of Rs 434.20 on the BSE after it informed exchanges, after market hours, on Friday that it has signed a licensing agreement with China Medical System Holdings for generic products in Mainland China. On the National Stock Exchange, Sun Pharma share price rose as much as 4.7 per cent to hit high of Rs 434.20 compared with its Friday's closing ...